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The regulator of G protein signaling (RGS)
domain of G protein–coupled receptor kinase 5
(GRK5) regulates plasma membrane localization
and function
Hua Xua,*, Xiaoshan Jianga,b,*, Ke Shenb, Christopher C. Fischera, and Philip B. Wedegaertnera
a

Department of Biochemistry and Molecular Biology, Thomas Jefferson University, Philadelphia, PA 19107; bCenter for
Science Research, Guilin Medical University, Guilin, Guangxi 541004, China

ABSTRACT The G protein–coupled receptor (GPCR) kinases (GRKs) phosphorylate activated
GPCRs at the plasma membrane (PM). Here GRK5/GRK4 chimeras and point mutations in
GRK5 identify a short sequence within the regulator of G protein signaling (RGS) domain in
GRK5 that is critical for GRK5 PM localization. This region of the RGS domain of GRK5 coincides with a region of GRK6 and GRK1 shown to form a hydrophobic dimeric interface (HDI)
in crystal structures. Coimmunoprecipitation (coIP) and acceptor photobleaching fluorescence
resonance energy transfer assays show that expressed GRK5 self-associates in cells, whereas
GRK5-M165E/F166E (GRK5-EE), containing hydrophilic mutations in the HDI region of the
RGS domain, displays greatly decreased coIP interactions. Both forcing dimerization of GRK5EE, via fusion to leucine zipper motifs, and appending an extra C-terminal membrane-binding
region to GRK5-EE (GRK5-EE-CT) recover PM localization. In addition, GRK5-EE displays a
decreased ability to inhibit PAR1-induced calcium release compared with GRK5 wild type
(wt). In contrast, PM-localized GRK5-EE-CaaX (appending a C-terminal prenylation and polybasic motif from K-ras) or GRK5-EE-CT shows comparable ability to GRK5 wt to inhibit PAR1induced calcium release. The results suggest a novel model in which GRK5 dimerization is
important for its plasma membrane localization and function.
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INTRODUCTION
The G protein–coupled receptor (GPCR) kinases (GRKs) specifically
phosphorylate agonist-activated GPCRs at the cytoplasmic surface
of the plasma membrane (PM). Phosphorylated GPCRs uncouple
the heterotrimeric G proteins and recruit arrestins to form receptor/
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arrestin complexes that undergo endocytosis, resulting in GPCR
degradation or recycling back to the PM. GRK-regulated desensitization of GPCR signaling can thus prevent an excessive cellular response to receptor activation and provides a necessary turn-off
mechanism to regulate GPCR signaling in response to variable
stimuli.
Seven GRK family members can be divided into three subgroups
based on their amino acid identity: GRK1 and 7; GRK2 and 3; and
GRK4–6. GRK1 and 7 are specifically expressed in the retina. The
other GRKs are ubiquitously expressed, except for GRK4, which is
mostly restricted to testes, brain, and kidney. All GRKs share similar
architecture. After a short N-terminal region, GRKs have a regulator
of G protein signaling (RGS) domain, a catalytic kinase domain, and
a variable C-terminal region (Gurevich et al., 2012).
To phosphorylate activated GPCRs in a timely manner, GRKs
need to localize to the cytoplasmic surface of the PM. The mechanisms used by GRKs to bind membranes remain to be fully elucidated, but it is clear that GRK C-termini play prominent roles. Of

Supplemental Material can be found at:
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FIGURE 1: Subcellular localization of GRK4–6. (A) HEK293 cells stably expressing GRK4, 5 or 6, as indicated, were
subjected to immunofluorescence staining using a GRK4–6 antibody that detects all three GRKs. Bar, 10 μm. (B) HEK293
cells stably expressing GRK4, 5, or 6 were lysed, and the cell lysates were fractionated by high-speed centrifugation into
soluble (S) and particulate (P) fractions, as described in Materials and Methods. GRKs were detected by immunoblotting
with a GRK4–6 antibody. The black bar indicates a 70-kDa standard. Images and immunoblots shown are representative
from at least three experiments.

interest, the C-terminal regions of the different GRK subfamilies are
quite diverse in terms of sequence and structure and indeed have
been shown to use unique mechanisms to promote GRK PM localization (Gurevich et al., 2012). GRK1 and 7 rely on a carboxyl-terminal CaaX motif that promotes covalent modification by a farnesyl or
geranylgeranyl isoprenoid (Inglese et al., 1992); these hydrophobic
lipids are well known to serve as membrane anchors. In contrast,
GRK2 and 3 each contains a pleckstrin homology (PH) domain in the
C-terminal region that mediates translocation of the kinases from
the cytoplasm to the PM upon GPCR activation (Pitcher et al., 1992;
Barak et al., 1999; Carman et al., 2000). The PH domain allows GRK2
and 3 to anchor on the PM by interacting with both phospholipids
and free G protein βγ subunits. Finally, GRK4–6 all have a predicted
C-terminal amphipathic helix motif defined by a hydrophobic helix
core surrounded by several basic residues (Pronin et al., 1998;
Thiyagarajan et al., 2004; Jiang et al., 2007). GRK5 and 6 appear to
localize constitutively at the PM in cells, but subcelluar localization
of GRK4 has not been well addressed. In addition to the amphipathic helix, GRK4 and 6 can be palmitoylated on C-terminal cysteines
(Stoffel et al., 1994; Premont et al., 1996; Loudon and Benovic,
1997; Vatter et al., 2005; Jiang et al., 2007). The covalent attachment of palmitate appears to be necessary, together with the
amphipathic helix, for PM localization of GRK6 (Jiang et al., 2007),
but the role of the amphipathic helix and palmitoylation in GRK4
remains to be examined.
To identify additional mechanisms that regulate PM localization
of GRK5, we compared the localization of GRK4–6 and then focused
on GRK5 in these studies. Surprisingly, whereas expressed GRK5
and 6 are localized on the PM, expressed GRK4 is found predominantly in the cytoplasm. Using GRK5/4 chimeras and point mutations in GRK5, we identify amino acids in the RGS domain of GRK5
that are necessary for PM localization. These amino acids map to a
region in GRK6 and 1 determined in crystal structures to mediate a
hydrophobic dimeric interface (HDI), and, consequently, we show
that expressed GRK5 can exist in a complex in cells. This study suggests a novel mechanism in which amino acids in the RGS domain of
GRK5 regulate its PM localization by mediating a dimeric
interaction.

RESULTS
GRK5/4 chimeras reveal a novel protein region involved
in PM localization of GRK5
Previous work demonstrated the importance of an amphipathic helix in the C-terminal extension of GRK5 and 6 for PM localization,
and for GRK6, palmitoylation in the C-terminal extension is also
2106 | H. Xu, X. Jiang, et al.

required (Stoffel et al., 1994, 1998; Loudon and Benovic, 1997;
Pronin et al., 1998; Thiyagarajan et al., 2004; Vatter et al., 2005;
Jiang et al., 2007). Although not yet tested for subcellular localization, the C-terminus of GRK4α (hereafter referred to as GRK4) likewise contains a predicted amphipathic helix and sites for palmitoylation (Premont et al., 1996; Pronin et al., 1998; Thiyagarajan et al.,
2004). However, when stably expressed in human embryonic kidney
(HEK293) cells, immunofluorescence microscopy demonstrated that
GRK4 was distributed throughout the cytoplasm, in contrast to the
strong PM localization of GRK5 and 6 (Figure 1A). Consistent with
the immunofluorescence analysis, separation of cell lysates by highspeed centrifugation into soluble/cytosol (S) or particulate/membrane (P) fractions revealed that GRK4 was found almost exclusively
in the soluble fraction, whereas GRK5 and 6 were predominantly
found in the particulate fraction (Figure 1B). These results indicate
an unexpected difference in subcellular localization among the
members of this subfamily of GRKs.
To identify the basis for this difference, we focused on a comparison of PM-localized GRK5 and cytoplasmic GRK4, and we first
tested whether differences in their C-termini could explain the dramatic difference in subcellular localization. GRK5 remains at the PM
when its C-terminus is replaced by that of GRK4 (Figure 2), indicating that the C-terminus of GRK4 has sufficient PM targeting information to compensate for the loss of GRK5’s C-terminus. Moreover,
GRK4 remains in the cytoplasm when its C-terminus is replaced by
that of GRK5 (Figure 2); thus, although the C-terminus of GRK5 is
required for GRK5 PM localization, it is not sufficient to promote PM
localization of GRK4. Taken together, these results show that C-terminal differences are not responsible for the different subcellular
localization of GRK5 and 4 and suggest that protein regions in addition to the C-terminus play a critical role in regulating PM localization of this GRK family.
Therefore we reasoned that additional GRK5/4 chimeras would
identify novel determinants of PM localization (Figure 2A). We
focused on the RGS domains because they contained the least
sequence identity in GRK5 versus GRK4. Replacing amino acids
95–134 in the RGS domain of GRK5 with amino acids 95–134 of
GRK4 did not affect localization; this GRK5/4RGS(95–134) chimera
remained localized at the PM similar to wt GRK5 (Figure 2). On the
other hand, a GRK5/4RGS(135–170) chimera, in which amino acids
135–169 of GRK5 were replaced with amino acids 135–170 of GRK4,
was localized in the cytoplasm (Figure 2). Thus a critical and novel
determinant for membrane localization of GRK5 appears to be contained within amino acids 135–169 of its RGS domain. Further mutagenesis showed that chimera GRK5/4RGS(165–169), which simply
Molecular Biology of the Cell

replaces four GRK5 amino acids within 165–169 with their GRK4
amino acid counterparts (M165S/F166Y/D168S/R169Q), was sufficient to shift localization of GRK5 into the cytoplasm and soluble
fraction (Figure 2).

A novel determinant of PM localization of GRK5 maps
to a hydrophobic dimeric interface

FIGURE 2: GRK5/4 chimeras identify a region of the RGS domain as a
novel determinant of PM localization of GRK5. (A) Schematic
representations of GRK chimeras. In GRK4/5CT(45), the C-terminus of
GRK4 (amino acids 548–577) is replaced with the C-terminus of GRK5
(amino acids 546–590). Conversely, in GRK5/4CT(30), the C-terminus
of GRK5 (amino acids 546–590) is replaced with that of GRK4 (amino
acids 548–577). Chimera GRK5/4RGS(95–134) was generated by
replacing a region of the RGS domain (amino acids 95–134) of GRK5
with the corresponding region of the GRK4 RGS domain (amino acids
95–134). Chimera GRK5/4RGS(135–170) was generated by replacing a
second part of the RGS domain (amino acids 135–169) of GRK5 with
the corresponding region of the GRK4 RGS domain (amino acids
135–170). Chimera GRK5/4RGS(165–169) was generated by replacing
amino acids 165–169 of GRK5 with the amino counterparts from
GRK4, resulting in the four amino substitutions M165S/F166Y/D168S/
R169Q in GRK5. (B) Plasmids expressing the indicated chimeras of
GRK5 and 4 were transiently transfected into HEK293 cells.
Immunofluorescence microscopy was performed using the GRK4–6
Volume 25 July 1, 2014

Strikingly, the region of the RGS domain identified in the foregoing
contains part of a conserved HDI identified in crystal structures of
GRK6 and 1 (Lodowski et al., 2006; Singh et al., 2008; Boguth et al.,
2010; Tesmer et al., 2012). The HDI in the crystal structure of GRK6
is composed of key hydrophobic residues I39, I165, Y166, and F527.
In GRK5, amino acids at the corresponding positions are I39, M165,
F166, and F527; the similarity of these key residues in GRK5 and
6 suggests that GRK5 would also contain an HDI (Figure 3A and
Supplemental Figure S1). Note that M165 and F166 are found
within the RGS domain region identified in Figure 2 as being critical
for PM localization of GRK5; in the GRK5/4RGS(135–170) and
GRK5/4RGS(165–169) chimeras, which show loss of PM localization,
M165 is replaced with a serine, along with other amino acid
substitutions.
To test more directly whether the HDI region of the RGS domain
plays a role in regulating GRK5 PM localization, we mutated three
key HDI-forming hydrophobic residues, M165, F166, and F527, to
negatively charged D or E in order to disrupt the ability of these side
chain to mediate hydrophobic interactions. Similar mutations to
negatively charged amino acids were shown to not affect the kinase
activity of GRK6 (Lodowski et al., 2006). Single mutants M165E,
F166E, and F527D and double mutants M165E/F166E (EE) and
M165E/F527D (ED) were expressed in HEK293 cells, and subcellular
localization was assayed by immunofluorescence microscopy and
subcellular fractionation. Of interest, all mutants showed much reduced PM localization compared with wt GRK5 (Figure 3B and
Supplemental Figure S2); the double mutants displayed prominent
localization in the cytoplasm, whereas the single mutants showed
strong cytoplasmic localization with a retention of some PM staining.
Fractionation analyses showed a decrease of membrane localization
for all GRK5 mutants (Figure 3C). Double mutant GRK5-EE showed
the highest loss of membrane binding; >65% of GRK5-EE was found
in the soluble fraction (Figure 3C). To examine the possibility that
the introduction of the negatively charged glutamic acids was preventing PM localization of GRK5 by decreasing binding to negatively charged membrane phospholipids, we generated two additional mutants. Both the neutral GRK5-M165A/F166A mutant and
the positive-charge GRK5-M165K/F166K mutant showed loss of PM
localization and membrane fractionation identical to GRK5-EE

antibody as described in Materials and Methods. Images shown are
representative from at least three experiments. Bar, 10 μm.
(C) Plasmids expressing the indicated chimeras of GRK5 were
transiently transfected into HEK293 cells, and subcellular fractionation
into soluble (S) and particulate (P) fractions was performed, as
described in Materials and Methods. GRK5 and 4 constructs were
detected after immunoblotting with a GRK4–6 monoclonal antibody
or a GRK4 polyclonal antibody, respectively. The black bar indicates a
70-kDa standard. The graph shows quantitation (average ± SD, n ≥ 3)
of gel bands of S and P fractions from multiple experiments. Statistical
analysis was performed using one-way analysis of variance (p < 0.05)
to indicate significant difference among all the groups, followed by
t-test comparison between any of the two groups. Asterisks indicate
statistical significance (p < 0.05) of the indicated S fraction vs. the
GRK5 S fraction or of the indicated P fraction vs. the GRK5 P fraction.
Dimerization and localization of GRK5
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(Figure 3, B and C), arguing against a specific role for the amino acid side chain’s
charge in disrupting PM localization of
GRK5. Taken together, these results show
that disruption of key hydrophobic residues
in the GRK5 HDI domain significantly impaired the PM targeting of GRK5, suggesting that this HDI domain contributes to
GRK5 PM localization.

HDI-mediated complex formation
of GRK5 in cells

FIGURE 3: A hydrophobic dimeric interface within the RGS domain is a novel determinant for
GRK5 PM targeting. (A) The region of the RGS domain of GRK5 identified in the
GRK5/4RGS(135–170) chimera is aligned with the same region of GRK4 and GRK6 (top
alignment), and a short region at the end of helix 11 of the RGS domains of GRK4–6 is also
aligned (bottom alignment). Key amino acids that are mutated here in GRK5 and that
correspond to amino acids that form important hydrophobic interactions in the dimeric structure
of GRK6 are underlined. (B) Plasmids expressing the following HDI mutants of GRK5 were
transiently transfected into HEK293 cells: GRK5 (wt), GRK5-M165E (M165E), GRK5-F166E
(F166E), GRK5-F527D (F527D), GRK5-M165E/F166E (EE), GRK5-M165E/F527D (ED), GRK5M165A/F166A (AA), and GRK5-M165K/F166K (KK). Immunofluorescence microscopy was
performed using the GRK4–6 antibody as described in Materials and Methods. Shown are
images of one to three cells under a 60× objective. Images shown are representative images
from at least three experiments. Bar, 10 μm. (C) Plasmids expressing the indicated HDI mutants
of GRK5 were transiently transfected into HEK293 cells, and subcellular fractionation into
soluble (S) and particulate (P) fractions was performed, as described in Materials and Methods.
GRK5 was detected after immunoblotting with a GRK4–6 antibody. The graph shows
quantitation (average ± SD, n ≥ 3) of gel bands of S and P fractions from multiple experiments.
Statistical analysis was performed using one way analysis of variance (p < 0.05) to indicate
significant difference among all the groups, followed by t-test comparison between any of the
two groups. Asterisks indicate statistical significance (p < 0.05) of the indicated S fraction vs. the
wt S fraction or of the indicated P fraction vs. the wt P fraction.
2108 | H. Xu, X. Jiang, et al.

GRK6 and GRK1 exist as HDI-mediated dimers in multiple crystal structures (Lodowski
et al., 2006; Singh et al., 2008; Boguth
et al., 2010; Tesmer et al., 2012). Although
the structure of GRK5 has not been reported, it is predicted, based on sequence
similarity, to contain a similar HDI domain
capable of mediating its homodimerization
(Figure 3A and Supplemental Figure S1).
However, it was reported that the purified,
palmitoylation-deficient mutant of GRK6
was a monomer in solution (Lodowski et al.,
2006), as was a nonfarnesylated, soluble
form of GRK1 (Singh et al., 2008), and purified, soluble GRK5 also behaves as a monomer in solution (J. Benovic, personal communication). Nonetheless, the authors
speculated that GRK6 and 1 may physiologically dimerize inside cells in the presence of membranes and interacting proteins (Lodowski et al., 2006; Singh et al.,
2008; Tesmer et al., 2012). The lack of dimer
detection of soluble GRK1, 5, or 6 suggests
that if self-association occurs in cells, it may
be weak and thus difficult to detect. Keeping this in mind, we sought to examine
whether GRK5 can form complexes in cells.
First, we examined complex formation
by coimmunoprecipitation. Because numerous attempts to coimmunoprecipitate different tagged forms of GRK5 from cell lysates
failed to provide reliable results, we used a
cell-permeable cross-linker to attempt to
trap GRK5 protein complexes before cell lysis. GRK5 tagged with S and hemagglutinin
(HA) epitopes, respectively, were expressed
in HEK293 cells, and, after treatment of the
cells with the cross-linker dithiobis[succinimi
dylpropionate] (DSP), cell lysates were subjected to an affinity precipitation assay to
pull down S-tagged GRK5 (GRK5-S) using
S-protein-agarose. In the precipitate, HAtagged GRK5 (GRK5-HA) was detected by
immunoblotting, suggesting an interaction
of the two tagged forms of GRK5 (Figure
4A). Identical pull-down assays with HDIdisrupted GRK5-EE revealed a lack of GRK5EE-S and GRK5-EE-HA coprecipitation, suggesting that GRK5 dimerization is dependent
on its HDI. To rule out the trivial explanation
Molecular Biology of the Cell

FIGURE 4: HDI-mediated self association of GRK5. (A) Pairs of S and HA epitope–tagged forms of GRK5, GRK5-EE,
GRK5-CaaX, or GRK5-EE-CaaX were transiently coexpressed in HEK293 cells as indicated. Cells were treated with the
cell-permeable cross-linker DSP, cells were then lysed, and affinity precipitation was performed with S-agarose beads.
The S-agarose pull down was immunoblotted with an HA antibody to detect coprecipitation of the two tagged forms of
GRK5 (top), and cell lysates were immunoblotted with HA antibody (middle) or S antibody (bottom). Immunoblots
shown are representative from at least three experiments. The black bars indicate a 70-kDa standard. The graph shows
quantitation (average ± SD, n = 3) of relative coprecipitation efficiency of the S- and HA-tagged forms of GRK5-EE-CaaX
(EE-CaaX) vs. the S- and HA-tagged forms of GRK5-CaaX (wt-CaaX). Quantitation of the pull-down gel bands of
GRK5-EE-CaaX and GRK5-CaaX (top) were normalized by the input cell lysate (middle). The asterisk indicates statistical
significance (t test, p < 0.05) of the relative coprecipitation efficiency of GRK5-EE-CaaX vs. GRK5-CaaX. (B–D) HEK293
cells were transfected with the indicated pairs of plasmids. As described in Materials and Methods, cells were imaged
by confocal microscopy. Merged images of the GFP and mCherry channels are shown. Bar, 10 μm. Regions of interest as
shown by the red rectangles in B were analyzed by acceptor photobleaching FRET. Fluorescence changes in the GFP
channel were determined before and after acceptor photobleaching of mCherry (50-s application of 543-nm
wavelength) in regions of interest (asterisk in B indicates the region of interest shown in C). (D) The FRET efficiency of
GRK5-GFP + GRK5-mCherry calculated from E = (ID − IDA)/ID, where ID is the peak in the presence of the sensitized
acceptor and IDA is the peak of donor (GFP) emission in the presence of the acceptor. The Gi2(1-10)-GFP + GRK5mCherry pair was used as negative and the GFP-DsRed as positive control for protein–protein interaction, respectively.
Each bar represents mean ± SEM of FRET efficiency, using six cells with three regions of interest per cell (n = 18).
Statistical analysis was performed using t-test comparison between groups. Asterisks (***) indicate statistical
significance (p < 0.0001). Similar results were obtained in three experiments.

that GRK5-EE is not detected in a complex in this assay due to its
localization in the cytoplasm rather than the PM, we generated PMlocalized forms of GRK5-EE by appending a C-terminal CaaX motif
from K-Ras. Although strongly targeted to the PM (Supplemental
Figure S3), S- and HA-tagged forms of GRK5-EE-CaaX were greatly
reduced in their ability to coprecipitate compared with tagged forms
of GRK5 or GRK5-CaaX (Figure 4A). Similarly, appending an additional C-terminus rescues PM localization of GRK5-EE (described
later in Figure 6) but does not promote coprecipitation (Supplemental Figure S4). Thus lack of PM localization does not explain the inability of GRK5-EE to coprecipitate in this assay. Instead, our results
using cross-linking followed by coprecipitation are consistent with
GRK5 forming dimers or higher-order complexes in cells, and mutation at the HDI disrupts this interaction.
In addition, we examined GRK5 complex formation using acceptor photobleaching fluorescence resonance energy transfer (FRET;
Figure 4, B–D). GRK5–green fluorescent protein (GFP) and GRK5mCherry were coexpressed in HEK293 cells and, as expected, colocalized on the PM (Figure 4B). On photobleaching the GRK5mCherry fluorescence in a region of interest at the PM, the GRK5-GFP
fluorescence was enhanced, indicating close association of GRK5GFP and GRK5-mCherry (Figure 4, C and D). A positive control in
which GFP and the red fluorescent protein DsRed2 are linked in a
single fusion protein gave a strong FRET signal (Figure 4, B–D). To
control for FRET that is simply a consequence of colocalization at
the PM rather than a protein–protein interaction, GFP was targeted
to the PM by virtue of fusion to the first 10 amino acids of the G
Volume 25 July 1, 2014

protein αi2 and was coexpressed with GRK5-mCherry (Figure 4B).
Much-reduced FRET was observed by the acceptor photobleaching
approach in cells expressing Gαi2-GFP and GRK5-mCherry (Figure
4, C and D), suggesting that the observed GRK5-GFP/GRK5mCherry interaction is not simply due to colocalization at the PM.
Taken together, the different experimental approaches in Figure 4
provide evidence for GRK5 self-association in transfected cells.

Forced dimerization of GRK5-EE rescues its impaired
PM targeting
We showed that disruption of the HDI in GRK5-EE resulted in decreased GRK5 complex formation and significant loss of GRK5 PM
localization (Figures 3 and 4), suggesting a model in which GRK5
dimerization is critical for its PM localization. Thus we hypothesized
that inducing dimerization of GRK5-EE would promote relocalization
of GRK5-EE to the PM. To test this prediction, we appended strongly
dimerizing leucine zipper motifs derived from the transcription factors Jun (JLZ) and Fos (FLZ; O’Shea et al., 1989; Patel et al., 1996;
Rieker and Hu, 2000; Stuhlmann-Laeisz et al., 2006) to GRK5-EE and
GRK5. JLZ-GRK5-EE and FLZ-GRK5-EE coimmunoprecipitated after
expression in HEK293 cells, consistent with the ability of the attached
leucine zipper motifs to promote dimerization (Figure 5C). Of importance, immunofluorescence microcopy in HEK293 cells showed that
leucine zipper–mediated GRK5-EE dimers (JLZ-GRK5-EE and FLZGRK5-EE) were relocalized on the PM compared with cytoplasmic
GRK5-EE (Figure 5A). Fractionation analysis of JLZ-GRK5-EE and
FLZ-GRK5-EE also demonstrated significant increase in membrane
Dimerization and localization of GRK5
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FIGURE 5: Leucine zipper–mediated dimerization of GRK5-EE rescues PM localization. (A) HEK293 cells were
transiently transfected with plasmids expressing S-tagged GRK5, S-tagged GRK5-EE, and S-tagged JLZ-GRK5 together
with HA-tagged FLZ-GRK5, or S-tagged JLZ-GRK5-EE together with HA-tagged FLZ-GRK5-EE. Immunofluorescence
microscopy was performed using a mouse monoclonal anti-S antibody followed by Alexa 594–conjugated secondary
antibody and a rabbit polyclonal anti-HA antibody followed by Alexa 448–conjugated secondary antibody. Nuclei were
stained with DAPI. Images shown are representative from at least three experiments. Bar, 10 μm. (B) HEK293 cells were
transiently transfected with the indicated constructs as described in A. Subcellular fractionation into soluble (S) and
particulate (P) fractions was performed, and samples were immunoblotted with a mouse monoclonal anti–GRK4–6
antibody. The black bars indicate a 70-kDa standard; the one on the left corresponds to lanes 1–4, and the one on the
right corresponds to the remaining lanes. The graph shows quantitation (average ± SD, n ≥ 3, except n = 2 for JLZ-wt,
JLZ-EE, FLZ-wt, and FLZ-EE) of gel bands of S and P fractions from multiple experiments. Statistical analysis was
performed using one way analysis of variance (p < 0.05) to indicate significant difference among all the groups, followed
by t-test comparison between any of the two groups. Asterisks indicate key statistical significance (p < 0.05) of the
indicated S fraction vs. the EE S fraction or of the indicated P fraction vs. the EE P fraction. (C) Pairs of S and HA
epitope–tagged forms of GRK5-EE or the S-tagged JLZ-GRK5-EE and HA-tagged FLZ-GRK5-EE pair were transiently
coexpressed in HEK293 cells as indicated. Cells were treated with the cell-permeable cross-linker DSP, cells were then
lysed, and affinity precipitation was performed with S-agarose beads. The S-agarose pull down was immunoblotted with
an HA antibody to detect coprecipitation of the two tagged forms of GRK5 (top), and cell lysates were immunoblotted
with HA antibody (middle) or S antibody (bottom). Each row is from the same immunoblot at the same film exposure;
intervening, irrelevant lanes were simply removed. The black bars indicate a 70-kDa standard. The graph shows
quantitation (average ± SEM, n = 3) of relative coprecipitation efficiency of the S- and HA-tagged forms of the indicated
GRK5 mutants. Quantitation of the pull-down gel bands (top) were normalized by the input cell lysate (middle). The
asterisk indicates statistical significance (t test, p < 0.05) of the relative coprecipitation efficiency of the S-tagged
JLZ-GRK5-EE and HA-tagged FLZ-GRK5-EE pair vs. the S-tagged GRK5-EE and HA-tagged GRK5-EE pair.

partitioning compared with that of GRK5-EE (Figure 5B), suggesting
that GRK5 dimerization is essential for its PM localization.

Tandem C-termini rescue PM localization of GRK5-EE
Our model predicts that monomeric GRK5 binds weakly to membranes inside cells, but dimerization allows bivalent or multivalent
interactions with membranes and thus strong membrane binding.
Thus we tested this idea by appending an extra C-terminal region
(residues 546–590), containing the amphipathic helix region re2110 | H. Xu, X. Jiang, et al.

quired for membrane binding, to the HDI-domain mutant GRK5-EE
and testing for rescue of PM localization. GRK5-EE-CT containing
such a tandem C-terminus localized prominently at the PM, as
opposed to the cytoplasmic localization of GRK5-EE (Figure 6A),
showing a striking shift to being predominantly in the membrane
fraction upon fractionation of cell lysates (Figure 6B). These results
are consistent with a model in which dimerization of GRK5 allows
membrane-binding domains from two molecules of GRK5 to contribute to PM localization.
Molecular Biology of the Cell

FIGURE 6: Tandem C-termini promote PM localization of GRK5-EE. (A) Plasmids expressing GRK5-EE, S-tagged
GRK5-CT, or S-tagged GRK5-EE-CT were transiently transfected into HEK293 cells. Immunofluorescence microscopy
was performed using a mouse monoclonal anti–GRK4–6 antibody or the mouse monoclonal anti-S antibody as
described in Materials and Methods. Images shown are representative from at least three experiments. Bar, 10 μm.
(B) Plasmids expressing GRK5-EE, S-tagged GRK5-CT, or S-tagged GRK5-EE-CT were transiently transfected into
HEK293 cells. Subcellular fractionation into soluble (S) and particulate (P) fractions was performed, and samples were
immunoblotted with a mouse monoclonal anti–GRK4–6 antibody or the mouse monoclonal anti-S antibody. The black
bars indicate a 70-kDa standard; the one on the left corresponds to lanes 1 and 2, and the one on the right corresponds
to the remaining lanes. The graph shows quantitation (average ± SD, n = 3) of gel bands of S and P fractions from
multiple experiments. Statistical analysis was performed using one-way analysis of variance (p < 0.05) to indicate
significant difference among all the groups, followed by t-test comparison between any of the two groups. Asterisks
indicate statistical significance (p < 0.01) of the indicated S fraction vs. the EE S fraction or of the indicated P fraction vs.
the EE P fraction.

Decreased cellular function of GRK5-EE is rescued by forced
PM localization
Previous work demonstrated that HDI mutations in GRK1 and GRK6
had little or no effect on phosphorylation of rhodopsin in vitro, suggesting that the HDI domain does not regulate the intrinsic kinase
activity of GRKs (Lodowski et al., 2006; Singh et al., 2008). Thus we
predicted that GRK5-EE would have decreased ability in cells to
regulate GPCR function due to its decreased PM localization. To test
this, we assayed the ability of expressed GRK5 to decrease Ca2+
signaling by the protease-activated receptor 1 (PAR1), an established target of GRK5 (Tiruppathi et al., 2000). Addition of thrombin
agonist peptide to HEK293 cells results in robust Ca2+ signaling, but
transient or stable overexpression of GRK5 reduces the Ca2+ response to 30–40% of that of cells transfected with empty vector
(Figure 7, A and B). In contrast, in HEK293 cells transiently or stably
overexpressing PM localization-deficient GRK5-EE, Ca2+ release
upon activation of PAR1 was 70% of that of control cells (Figure 7, A
and B). As a comparison, GRK5-4A, containing mutations of the four
key hydrophobic residues in the C-terminal amphipathic helix
membrane-binding region (Thiyagarajan et al., 2004), is likewise deficient in inhibiting PAR1-mediated Ca2+ signaling (∼80% of control)
compared with wt GRK5 (Figure 7A), consistent with decreased localization at the PM. When HEK293 cells were transiently transfected
with PM-bound GRK5-EE-CT or GRK5-EE-CaaX, PAR1-mediated
Ca2+ signaling was inhibited in a manner similar to that seen with
GRK5 (Figure 7, C and D), showing that restoration of PM localization can recover the decreased function of GRK5-EE.

DISCUSSION
This article demonstrates a key role for a surface of the RGS domain
of GRK5 in regulating its PM localization. The results provide evidence for a novel PM targeting mechanism in which RGS domain–
mediated dimerization is necessary for PM localization of GRK5.
Several lines of evidence support this. First, chimeras and site-specific mutations show that disruption of select RGS-domain amino
acids results in loss of PM localization of GRK5. Moreover, these
amino acids map to a surface of the RGS domain that was observed
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to mediate dimeric interactions in crystal structures of GRK6 and 1.
Second, cross-linking coprecipitation studies and FRET show GRK5–
GRK5 complex formation in transfected cells. Third, recovery of PM
localization of the cytoplasmic GRK5 RGS domain mutant by forced
dimerization or by appending an additional membrane-targeting Cterminal region provides further support for a model in which dimerization allows multivalent membrane binding of GRK5.
RGS domain–mediated dimerization of GRK5 is supported by
recent crystal structures of GRK6 and 1 in which an extensive surface
area forms an HDI. The overall structure of the RGS domain and the
dimeric surface are highly similar in GRK6 and 1, and the two GRKs
use very similar amino acids to form the HDI. Of importance, GRK5
is also predicted to form a similar HDI based on amino acid identity
(Lodowski et al., 2006; Figure 3A and Supplemental Figure S1). Of
interest, dimers of purified GRK6 or 1 could not be detected in solution (Lodowski et al., 2006; Singh et al., 2008). However, those studies used a soluble palmitoylation-deficient mutant of GRK6 and a
soluble nonfarnesylated form of GRK1. It is possible that binding to
membranes facilitates the formation of dimers and that dimers could
exist inside the cell in the presence of membranes and other proteins. This would suggest that dimerization of these GRKs is dynamic inside the cell. Indeed, we were initially unable to reproducibly coimmunoprecipitate different tagged forms of GRK5,
suggesting that GRK5 dimers were not stable upon cell lysis, but the
use of a cell-permeable cross-linker before cell lysis allowed us to
capture GRK5 complexes. Of importance, mutation of M165 and
F166 (GRK5-EE), two key amino acids in the predicted HDI of GRK5,
disrupted complex formation in our coprecipitation assay (Figure
4A), even when GRK5-EE was localized to the PM by virtue of a
CaaX motif. In addition, a report showed coimmunoprecipitation of
different tagged forms of GRK5, although mutational disruption of
the coimmunoprecipitated complex was not tested (Chen et al.,
2011). Consistent with disruption of dimerization by our mutations
in GRK5, another report showed that a L166K mutation in GRK1,
mapping to the same position as M165 in GRK5, resulted in the first
crystal structure of GRK1 as a monomer (Tesmer et al., 2012). The
L166K mutation did not perturb the overall structure of GRK1; it only
Dimerization and localization of GRK5
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disrupted the ability of GRK1 to crystallize as a dimer. A key future
question is whether one can detect self-association of endogenous
GRKs, specifically GRK1, 5, or 6. This a very challenging question, as
there exists a dearth of techniques for demonstrating homodimerization of an endogenous nontagged protein.
In addition to suggesting that GRK5 dimerizes in the cell to promote PM localization, our results raise the possibility that lack of dimerization of GRK4 may be responsible for our observation that
expressed GRK4 is cytoplasmic rather than localized to the PM
(Figures 1 and 2). Although RGS domain sequence comparisons indicate that GRK2 and 3 do not have an HDI, all other GRKs were
predicted to have a similar HDI capable of mediating dimerization
(Lodowski et al., 2006). However, our GRK5/4 chimeras indicate important differences in the two RGS domains in terms of promoting
PM localization, and closer inspection of the RGS sequence identifies key amino acid differences that might prevent formation of a
HDI in GRK4. Specifically, GRK6 and 1 dimerize in crystal structures
using a central interdigitated aromatic stack and additional hydrophobic interactions composed of amino acids I39/I165/Y166/F527
and L44/L166/Y167/W531, respectively, and GRK5 has a similar predicted hydrophobic core consisting of I39/M165/F166/F527. However, the amino acids at the similar positions in GRK4 are V39/S166/
Y167/S528. The presence of S166 rather than a hydrophobic isoleucine, leucine, or methionine and the presence of S528 rather than
the hydrophobic phenylalanine or tryptophan would be predicted
to prevent the formation of an HDI in GRK4. Thus we speculate that
the observed cytoplasmic localization of GRK4 (Figures 1 and 2) reflects an inability of GRK4 to dimerize, and, moreover, we predict
that introduction of an HDI into GRK4 would promote its PM localization. Initial attempts to test this idea by generating GRK4/GRK5
chimeras failed to relocalize GRK4 to the PM. Certainly, it is easier to
generate loss-of-function/localization than gain-of-function/localization mutants, and the mechanism behind the localization differences
of GRK5 and 4 remain to be understood.
One functional role for dimerization of GRK5 appears to be simply to regulate PM localization. We showed that the cytoplasmic HDI
mutant GRK5-EE less efficiently reduced PAR1-mediated calcium
signaling than PM-localized GRK5 wt; however, returning GRK5-EE
to the PM by appending a CaaX motif or an additional GRK5 C-terminus allowed GRK5-EE to function similarly to GRK5 wt (Figure 7).
Consistent with this, it is worth noting that other reports have shown
that mutation of key HDI residues in GRK1, 6, and 5 do not affect
kinase activity and phosphorylation of GPCRs in vitro (Lodowski
et al., 2006; Singh et al., 2008; Baameur et al., 2010). However, we
cannot rule out that GRK5 dimerization has functional roles independent of regulating PM localization. In this regard, Chen et al. (2011)
proposed that dimerization of GRK5 is necessary for a novel role of

FIGURE 7: Regulation of PAR1-mediated signaling by GRK5-EE.
(A) HEK293 cells were either stably or transiently transfected with
vector (V), GRK5 (wt), GRK5-EE (EE), or GRK5-4A (4A) as indicated.
The cells were treated with 100 nM PAR1 agonist peptide. The
change of cytoplasmic calcium concentration was measured using a
Fura-2 calcium mobilization assay described in Materials and
Methods. Briefly, the calcium concentration reflected by the ratio of
emission at 340/380 nm (y-axis) was recorded over time of stimulation
(x-axis). The peak value (the distance between the top of the peak
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and baseline) of the calcium concentration curve was calculated to
reflect the maximal magnitude of PAR1 signaling activation for each of
the transfected samples. (B, C) PAR1 peptide agonist–stimulated
calcium release was measured in HEK293 cells stably expressing
GRK5 or GRK5-EE or HEK293 cells transiently expressing GRK5,
GRK5-EE, GRK5-CT, GRK5-EE-CT, GRK5-CaaX, or GRK5-EE-CaaX, as
indicated. The peak value of the calcium concentration in vector
transfected cells was normalized as arbitrary unit 1. Statistical analysis
was performed using one-way analysis of variance (p < 0.05) to
indicate significant difference among all the groups, followed by t-test
comparison between any of the two groups (B and C, n = 3).
*p < 0.05. (D) Cell lysates from a representative experiment of
transiently transfected HEK293 cells were immunoblotted using the
GRK4–6 antibody. The black bar indicates a 70-kDa standard.
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GRK5 in actin bundling. Future studies will be needed to fully define
the role of the HDI region of the RGS domain in GRK5 function.
We propose a refined model for the mechanisms that regulate
PM localization of GRK5. Previous work showed that the C-terminal
region of GRK5 was a critical determinant of PM localization, and
our previous studies predicted that a C-terminal amphipathic helix
was crucial (Pronin et al., 1998; Thiyagarajan et al., 2004; Jiang et al.,
2007). The C-terminal amphipathic helix, which is also present in
GRK4 and GRK6, is proposed to bind membranes through a central
patch of hydrophobic amino acid side chains and also by surrounding basic amino acids that would interact with acidic membrane lipid
headgroups. In addition, GRK5 can interact with membranes via an
N-terminal basic region shown to bind phosphatidylinositol 4,5-bisphosphate (PIP2; Pitcher et al., 1996; Chen et al., 2011). Whether
the N-terminal PIP2-binding motif directs PM localization or modulates membrane domain localization and kinase activity once GRK5
is localized to the PM remains to be clearly defined. Nonetheless, it
is clear that multiple regions of GRK5 can contribute to PM localization. However, our results predict that such membrane-binding regions promote only weak membrane localization of monomeric
GRK5 inside the cell. Consequently, dimerization of GRK5 would
allow multivalent and therefore strong membrane binding. Consistent with this idea, our previous work showed that whereas the Cterminal amphipathic helix region of GRK5 was necessary for PM
localization, when fused to GFP it only promoted partial PM localization, suggesting that the C-terminus is a weak membrane-targeting
signal (Thiyagarajan et al., 2004). Following from this idea, in this
study PM localization of cytoplasmic GRK5-EE was recovered when
an additional C-terminus was fused to it. We propose that in the
absence of RGS domain–mediated dimerization, the additional Cterminus mimicked the multivalent membrane binding that would
be promoted by GRK5 dimerization. Such dimerization-facilitated
strong membrane localization has been observed in other proteins.
For example, dimerization has been shown to be necessary for
phosphatidylinositol 3-phosphate–binding FYVE domains to promote strong localization to endosomal membranes (Hayakawa et al.,
2004; Cho and Stahelin, 2005).
Taken together, previous work and our results here suggest a
novel model in which dimerization of GRK5 is critical for PM localization. Regulation of the ability of GRK5 to dimerize would provide a
point of regulation of GRK5’s localization and function inside the
cell. Moreover, the development of an inhibitor to disrupt GRK5
self-association, and thus PM localization and function, may provide
a way to specifically target GRK5 in disease.

Materials and methods
Cell culture
HEK293 cells were cultured in DMEM supplemented with 10% fetal
bovine serum (FBS) and 1% penicillin and streptomycin. All cell lines
were incubated in a 5% CO2 atmosphere at 37°C.

Constructs
The full-length human GRK5 in pcDNA3 construct was provided by
Jeffrey Benovic (Thomas Jefferson University, Philadelphia, PA;
Kunapuli and Benovic, 1993). Human GRK4α was generously provided by Richard Premont (Duke University, Durham, NC) and was
subcloned into pcDNA3. Single or double mutations of the RGS
domain, as well as the quadruple mutant GRK5/4RGS(165–169),
were generated using QuikChange (Stratagene) site-directed mutagenesis. S tag (KETAAAKFERQHMDS) or HA tag (YPYDVPDYA)
was fused at the carboxy terminus of GRK5 constructs. To generate leucine zipper constructs, the nucleotide fragments of the
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Jun leucine zipper (JLZ) motif (RIARLEEKVKTLKAQNSELASTANMLREQVAQLKQKVMN) and the Fos leucine zipper (FLZ) motif (LTDTLQAETDQLEDEKSALQTEIANLLKEKEKLEFILAA) were amplified
by PCR. Following an initiating methionine, each motif sequence
was appended to the N-terminal end of GRK5 by a peptide linker
(GGSGGGSGGGSG). Tandem C-termini constructs were generated
by linking a GRK5 C-terminal region (amino acids 546–590) to the
C-terminal end of full-length GRK5 following a peptide linker
(DSAGSAG). To make GRK5 CaaX constructs, a K-Ras4B CaaX tail
(GKKKKKKSKTKCVIM) was directly appended downstream of the S
or HA tags of GRK5 constructs. All the constructs were cloned into
pcDNA3.1 or pcDNA3 vector.

Plasmid transfection
For transient transfection, cells were seeded at 40–50% confluency
in cell culture dishes overnight. Plasmids were mixed with Lipofectamine 2000 reagent (Invitrogen, Grand Island, NY) at reagentto-DNA ratio of 3:1 according to manufacturer’s protocol. The mixture was placed in the cell dishes, and the cells were incubated for
48 h before further analysis. The stable line of GRK5-expressing
HEK293 cells was also generated for this study. Briefly, GRK5 plasmids were transfected into HEK293 cells, and positive clones were
screened in the presence of G418.

Immunofluorescence microscopy
Cells were fixed in 3.7% formaldehyde on coverslips for 15 min,
followed by incubation in TBS solution supplemented with 1%
Triton X-100 (TBS-Triton) and 2.5% milk for blocking for 20 min.
Then cells were incubated with primary antibodies (mouse monoclonal anti-S tag [Novagen, Darmstadt, Germany], rabbit polyclonal anti-HA tag [Santa Cruz, Biotechnology, Dallas, TX], and
mouse monoclonal anti-GRK4-6 [Millipore, Darmstadt, Germany])
at dilution of 1:1000 (for all the primary antibodies used) in TBSTriton solution with 2.5% milk for 1 h at room temperature, followed by five washes with TBS-Triton solution with 2.5% milk.
Cells were then incubated with anti-mouse and anti-rabbit secondary antibodies preconjugated with Alexa 488 or Alexa 594
(Invitrogen) at dilution of 1:100 (for both secondary antibodies) in
TBS-Triton solution with 2.5% milk for 30 min at room temperature, followed by five washes with TBS-Triton solution. The nuclei
were stained with 4′,6-diamidino-2-phenylindole (DAPI). Coverslips were mounted to glass slides in Prolong Gold antifade
mounting medium (Invitrogen) overnight. Images were recorded
with an Olympus BX-61 microscope (Olympus, Melville, NY) and
60× planApo objective with an ORCA-ER (Hamamatsu, Bridgewater, NJ) cooled charge-coupled device camera controlled by
SlideBook, version 4.0 (Intelligent Imaging Innovation, Denver,
CO). Images were transferred to Photoshop (Adobe, San Jose,
CA) for digital processing.
Quantitation of single cells was performed after deconvolution.
Image stacks were deconvolved using a constrained iterative algorithm in SlideBook, version 4.0, and images of xy-planes through
the middle of cells were used for analysis. Quantitation of deconvolved images of single cells was performed using the Plot Profile
tool of ImageJ (National Institutes of Health, Bethesda, MD). The
relative magnitude GRK5 distribution along a linear slice of the cell
was quantitated, similar to that described previously (Thiyagarajan
et al., 2002; Irannejad et al., 2013). The pixel intensity in eight or
nine line scans from four or more cells for each GRK5 mutant was
determined, the pixel intensity was normalized to 1, and then the
average pixel intensity was plotted using Prism (GraphPad, La
Jolla, CA).
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Affinity pull-down assay
The transfected cells were treated with cross-linker DSP (Invitrogen) at 2 μM final concentration in phosphate-buffered saline (PBS)
buffer for 30 min at room temperature according to manufacturer’s
protocol. The cells were then lysed in Triton lysis buffer (1% Triton
X-100, 25 mM Tris-HCl, pH 7.4, 150 mM NaCl, 5% glycerol, 1 mM
EDTA, 2 mM Na3PO4, 1 mM NaF, 20 mM Na4P2O7) supplemented
with protease inhibitor tablet (Roche, Basel, Switzerland) on ice for
15–30 min. Cell lysates were spun down at low speed, and the supernatant was collected for total protein quantification. Equivalent
amounts (400–600 μg) of total protein lysate from each sample
were incubated with 30 μl of S-agarose beads (Novagen) through
rotation for 1–2 h at 4°C. The S-agarose beads were then washed
three times with Triton lysis buffer before being mixed in sample
buffer for SDS–PAGE electrophoresis.

Calcium mobilization assay
The transfected cells were detached from Petri dishes in cell stripper
solution (Cellgro, Manassas, VA) and collected in 15-ml conical
tubes in Hank’s balanced salt solution (HBSS) buffer at 5 × 106 cells/
ml. The cells were incubated with 3 μM Fura-2 (Invitrogen) in the
dark for 30 min at 37°C. Then the cells were washed and resuspended in HBSS buffer supplemented with 0.025% bovine serum
albumin. To induce intracellular calcium release, 2 × 106 cells of each
sample in 1.6-ml volume were stimulated with PAR1 agonist peptide
(SFLLRN; GenScript, Piscataway, NJ) at 100 nM. Cytoplasmic calcium concentration was measured by a fluorescence spectrometer
using excitation at 340 and 380 nm according to the manufacturer’s
protocol. The calcium release was recorded by FL WinLab
program.

Western blotting
Protein samples were mixed with sample buffer and boiled for 10 min
before SDS–PAGE. The separated proteins were transferred onto a
polyvinylidene fluoride membrane. The membrane was blocked for
1 h in TBST buffer supplemented with 5% milk. The protein of interest was probed with the indicated primary antibodies overnight at
4°C, followed by horseradish peroxidase–conjugated secondary antibody for 1 h at room temperature. The protein of interest was detected using an enhanced chemiluminescence reaction.

Fractionation assay
The transfected cells were scraped off the culture dishes and suspended in detergent-free hypotonic buffer (50 mM Tris-HCl, pH 8,
2.5 mM MgCl2, 1 mM EDTA) supplemented with protease inhibitors
(Roche). Cells were pushed through a 21-gauge needle 10 times.
Cell lysates were spun down at 400 × g for 5 min to discard nuclei
and cell debris. The supernatants were collected and subjected to
ultracentrifugation at 150,000 × g for 20 min to separate soluble/
cytosol portion (S) from particulate/membrane portion (P). Identical
cell equivalents from the P and S fractions were analyzed by immunoblotting. Quantity One software (Bio-Rad, Hercules, CA) and ImageJ were used to scan films from three independent experiments
and quantitate S and P immunoblot bands. Immunoblotting with
HSP90 and Na/K ATPase antibodies shows that this method effectively separates cytosol and membranes, respectively (unpublished
data).

Acceptor photobleaching fluorescence resonance
energy transfer
HEK293 cells cultured in Falcon six-well plates (Becton Dickinson,
Franklin Lakes, NJ) were transfected with 2 μg of 1) a plasmid pair of
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pEGFP(N1)-GRK5 and pmCherry(N1)-GRK5, 2) a plasmid pair of
pEGFP(N1)-Gi2(1-10) and pmCherry(N1)-GRK5, or 3) a control plasmid pEGFP(N1)-DsRed2, respectively. Twenty-four hours after transfection, cells were replated (3 × 105 cells/well) onto coverslips.
Twenty-four hours after replating, cells were fixed in 3.7% formaldehyde in PBS for 20 min at room temperature, washed with PBS, and
mounted onto slides. For the acceptor photobleaching FRET, a 63×
magnification/1.4 numerical aperture oil immersion objective was
used with the pinhole for visualization, and images were obtained
by placing the slide onto a stage in a Zeiss LSM710 confocal microscope (Carl Zeiss, Jena, Germany). Three regions of each cell were
acceptor-photobleached. The 488-nm laser line was used for imaging GFP, and the 543-nm laser line was used for the acceptor-photobleaching. FRET efficiency (E) was calculated from the GFP channel
images according to E = (ID − IDA)/ID, where ID is the peak in the
presence of the sensitized acceptor and IDA is the peak of donor
emission in the presence of the acceptor. Before and after the
bleaching of mCherry, GFP images were collected to assess changes
in donor fluorescence. To ensure similar expression levels when
comparing the two sample sets GRK5-GFP/GRK5-mCh and
Gi(1-10)-GFP/GRK5-mCh, cells for analysis were used for which
1) GFP and mCh intensities were similar between the two sample
sets and 2) the mCh/GFP intensity ratios were similar between the
two sample sets.

Statistical analysis
All the statistical analyses were performed using Prism. p < 0.05 was
considered statistically significant.
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